Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$276M |
| 2 |
Procter & Gamble
PG
|
+$243M |
| 3 |
Analog Devices
ADI
|
+$188M |
| 4 |
Advanced Micro Devices
AMD
|
+$171M |
| 5 |
Home Depot
HD
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.95B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$778M |
| 3 |
Walmart Inc
WMT
|
+$723M |
| 4 |
Zoom
ZM
|
+$642M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.93% |
| 2 | Technology | 16.65% |
| 3 | Consumer Staples | 12.19% |
| 4 | Consumer Discretionary | 9.52% |
| 5 | Communication Services | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Brink's
BCO
$4.88B
| $10.8M | 0.01% |
262,800
-208,400
| -44% | -$9.19M |
|
|
AMRN
1077
Amarin Corp
AMRN
$299M
| $10.8M | 0.01% |
128,049
-62,614
| -33% | -$7.5M |
|
1078
Mizuho Financial
MFG
$127B
| $10.8M | 0.01% |
4,220,400
-309,400
| -7% | -$812K |
|
1079
Retractable Technologies
RVP
$19.8M
| $10.8M | 0.01% |
1,614,368
+72,471
| +5% | +$576K |
|
1080
Mesa Laboratories
MLAB
$564M
| $10.7M | 0.01% |
42,100
-7,000
| -14% | -$1.66M |
|
1081
BlackBerry
BB
$4.98B
| $10.7M | 0.01% |
2,325,355
+1,106,071
| +91% | +$5.35M |
|
1082
Seres Therapeutics
MCRB
$46.8M
| $10.7M | 0.01% |
18,840
-50,825
| -73% | -$16.9M |
|
1083
WPP
WPP
$4.36B
| $10.7M | 0.01% |
271,529
-129,843
| -32% | -$5.14M |
|
|
KDNY
1084
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $10.7M | 0.01% |
876,802
-52,060
| -6% | -$698K |
|
1085
Center Bancorp
CNOB
$1.66B
| $10.6M | 0.01% |
755,856
-79,000
| -9% | -$1.15M |
|
|
EVRI
1086
DELISTED
Everi Holdings
EVRI
| $10.6M | 0.01% |
1,287,600
-1,374,900
| -52% | -$9.54M |
|
1087
Euronet Worldwide
EEFT
$2.72B
| $10.6M | 0.01% |
116,245
-55,500
| -32% | -$5.42M |
|
1088
Bruker
BRKR
$9.57B
| $10.6M | 0.01% |
265,810
-397,900
| -60% | -$16.6M |
|
1089
Texas Capital Bancshares
TCBI
$4.3B
| $10.6M | 0.01% |
339,400
-500
| -0.1% | -$15.8K |
|
1090
Southwest Gas
SWX
$6.47B
| $10.6M | 0.01% |
167,400
-66,100
| -28% | -$4.42M |
|
|
ADAP
1091
DELISTED
Adaptimmune Therapeutics
ADAP
| $10.5M | 0.01% |
1,321,611
-383,800
| -23% | -$3.36M |
|
1092
Popular Inc
BPOP
$11.2B
| $10.5M | 0.01% |
290,327
-18,048
| -6% | -$669K |
|
1093
York Water
YORW
$502M
| $10.5M | 0.01% |
248,636
-31,100
| -11% | -$1.42M |
|
|
PTNR
1094
DELISTED
Partner Communications
PTNR
| $10.5M | 0.01% |
2,687,951
+1,400
| +0.1% | +$5.59K |
|
|
GRP.U
1095
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $10.5M | 0.01% |
180,400
+79,100
| +78% | +$4.52M |
|
1096
Blue Owl Capital
OBDC
$5.34B
| $10.5M | 0.01% |
867,900
+552,100
| +175% | +$6.76M |
|
1097
MillerKnoll
MLKN
$1.53B
| $10.5M | 0.01% |
346,965
+65,000
| +23% | +$1.61M |
|
|
CIT
1098
DELISTED
CIT Group Inc.
CIT
| $10.5M | 0.01% |
590,100
-6,002
| -1% | -$115K |
|
1099
Diageo
DEO
$49B
| $10.4M | 0.01% |
75,800
-297,933
| -80% | -$41.1M |
|
1100
Kirby Corp
KEX
$7.01B
| $10.4M | 0.01% |
+288,400
| New | +$12.7M |
|
Similar funds
Renaissance Technologies's Q3 2020 Portfolio in Review
As of Q3 2020, Renaissance Technologies held 3,879 positions worth $100B, down 14% from $116B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Renaissance Technologies withdrew a net $21.7B in Q3 2020, closing 544 positions and reducing 1,671 holdings. Its most notable exit was Alibaba, an estimated $426M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Microsoft worth $277M.
- Renaissance Technologies's largest Q3 2020 buy was Microsoft: 1,315,812 shares worth $277M.
- Renaissance Technologies added most to Procter & Gamble in Q3 2020, an estimated $243M increase.
- Renaissance Technologies's biggest Q3 2020 reduction was Tesla, cutting an estimated $1.95B.
- Renaissance Technologies fully exited Alibaba in Q3 2020, selling an estimated $426M.
- Renaissance Technologies's ten largest holdings make up 15% of its $100B portfolio in Q3 2020.
- Renaissance Technologies opened 490 new positions and closed 544 in Q3 2020.
- Renaissance Technologies's portfolio value fell 14% quarter-over-quarter to $100B.
Based on Renaissance Technologies's 13F filing for Q3 2020, filed 13 Nov 2020.